Related content

Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages

By              

International Journal of Oncology, Vol. 40, Iss. 2, 2012-01 ,pp. : 427-435

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing’s sarcoma cells

By Sonnemann Jürgen   Dreyer Linn   Hartwig Maite   Palani Chithra   Hong Le   Klier Ulrike   Bröker Barbara   Völker Uwe   Beck James  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 847-858

Springer Publishing Company

Access to resources Recommend Favorite

Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo

By                  

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 451-458

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2908-2912

Spandidos Publications

Access to resources Recommend Favorite

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

By                      

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 10-16

Spandidos Publications

Access to resources Recommend Favorite